Replacement Sensors: Your Safety Net Against Crisis
Sensor failures happen. Having no replacement increases the risk of overnight lows or highs. Most insurance plans restrict quantity. Discount routes help create a buffer. Sally shared in a recent post: “I had no more, and insurance wouldn’t cover it yet.” Backups aren’t a luxury—they’re a safety strategy. Every small act of sharing creates a ripple. If this piece resonated with you, consider sending it to someone who might need the same hope today—or leave us a comment in the section below with your own saving story so thousands can benefit from it. No one should have to navigate the cost of illness alone. Checked and verified active December, 2025. CGM safety and risk when sensors are unavailable American Diabetes Association (ADA) — Continuous Glucose Monitors (CGMs): Clinical Safety Overview National Institutes of Health (NIH) / PubMed Central — CGM Use and Reduction of Acute Glycemic Events Journal of Diabetes Science and Technology — Impact of CGM Data Gaps on Patient Safety Insurance quantity limits and replacement barriers Centers for Medicare & Medicaid Services (CMS) — Continuous Glucose Monitor Coverage & Supply Limits Patient Advocate Foundation — Diabetes Technology Access and Replacement Appeals Manufacturer replacement and backup strategies Dexcom — Sensor Replacement Policy and Product Support U.S. Food & Drug Administration (FDA) — Medical Device Malfunction Reporting (CGMs) Emergency prevention and cost avoidance Centers for Disease Control and Prevention (CDC) — Severe Hypoglycemia: Prevention and Risks Agency for Healthcare Research and Quality (AHRQ) — Preventing Avoidable Diabetes Emergencies
What’s happening
— Sally FigueroaWhat you can do
What to avoid
How to move forward
Our Pay It Forward Approach
Verification Note
All sources are government, nonprofit, peer-reviewed, or FDA-regulated primary sources relevant to CGM safety, replacement limitations, and patient protection.
Confirms CGMs reduce severe hypoglycemia and hyperglycemia events and emphasizes continuous access as a safety requirement.
https://diabetes.org/diabetes/technology/continuous-glucose-monitors-cgms
Peer-reviewed evidence showing that interruptions in CGM access increase risk of unrecognized glucose excursions.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397018/
Demonstrates that gaps in CGM monitoring are associated with delayed treatment of hypoglycemia and hyperglycemia.
https://journals.sagepub.com/doi/10.1177/1932296819891304
Federal documentation outlining quantity limits, refill timing, and replacement policies for CGM supplies under Medicare and many commercial plans.
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33822
Nonprofit guidance on navigating early replacement denials, medical-necessity letters, and emergency coverage gaps.
https://www.patientadvocate.org/explore-our-resources/chronic-illness/diabetes/
Official manufacturer guidance on sensor failures, early detachment, and replacement eligibility.
https://www.dexcom.com/support/sensor-replacement-policy
Federal reporting and safety framework recognizing sensor failure as a known device risk category.
https://www.fda.gov/medical-devices/medical-device-safety
Confirms that delayed detection of glucose extremes increases emergency department utilization and hospitalization risk.
https://www.cdc.gov/diabetes/basics/low-blood-sugar.html
Government research linking continuous monitoring and proactive planning to reduced emergency costs.
https://www.ahrq.gov/prevention/quality-diabetes-care.html